Back to Search Start Over

Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial.

Authors :
Guler OC
Onal C
Source :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 May; Vol. 167, pp. 164-165. Date of Electronic Publication: 2022 Mar 10.
Publication Year :
2022

Abstract

Competing Interests: Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Subjects

Subjects :
Androgen Antagonists
Androgens
Clinical Trials, Phase III as Topic
Humans
Male
Randomized Controlled Trials as Topic
Prostatic Neoplasms drug therapy
Prostatic Neoplasms radiotherapy

Details

Language :
English
ISSN :
1879-0852
Volume :
167
Database :
MEDLINE
Journal :
European journal of cancer (Oxford, England : 1990)
Publication Type :
Editorial & Opinion
Accession number :
35282967
Full Text :
https://doi.org/10.1016/j.ejca.2022.01.041
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details